Medivir

1,89 SEK

-7,13%

Mindre end 1K følgere

MVIR

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Kvartalsdata

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Medivir

Q4/242024Q1/25Q2/25Q3/25Q4/252025Q1/26
Omsætning1,03,50,61,50,95,58,51,0
EBITDA-26,2-124,6-12,6-22,5-12,9-12,0-60,1-8,8
EBIT-26,9-127,3-13,3-23,2-13,6-42,5-92,6-9,4
EBIT-%-2.690,0 %-3.637,1 %-2.216,7 %-1.546,7 %-1.511,1 %-772,7 %-1.089,4 %-940,0 %
Overskud før skat-26,7-123,3-13,3-23,3-14,6-43,2-94,4-9,4
Netto indkomst-26,7-123,3-13,3-23,3-14,6-43,2-94,4-9,4